CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
118.50
0.00 (0.00%)
Aug 29, 2025, 1:30 PM CST
Market Cap12.18B
Revenue (ttm)1.68B
Net Income (ttm)364.31M
Shares Out102.80M
EPS (ttm)3.53
PE Ratio33.59
Forward PEn/a
Dividend4.10 (3.46%)
Ex-Dividend DateAug 21, 2025
Volume157,136
Average Volume266,481
Open118.50
Previous Close118.50
Day's Range116.50 - 119.00
52-Week Range71.10 - 123.50
Beta0.15
RSI81.34
Earnings DateAug 15, 2025

About CH Biotech R&D

CH Biotech R&D Co., Ltd., a biotech company, engages in the research and development of biotech drugs for agrochemical products in Taiwan, the United States, and internationally. The company offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is based in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2024, CH Biotech R&D's revenue was 1.64 billion, an increase of 7.98% compared to the previous year's 1.51 billion. Earnings were 476.39 million, an increase of 2.83%.

Financial Statements

News

There is no news available yet.